# Question 58

**Type:** Survival Analysis - Gene Alteration

**Question:** In the “Pan-cancer analysis of whole genomes” study what is the survival difference and the corresponding statistical significance between patients with mutations in both TP53 and KRAS versus patients with only a KRAS mutation?

**Answer:**

**URL**: https://www.cbioportal.org/results/survival?Action=Submit&RPPA_SCORE_THRESHOLD=2.0&Z_SCORE_THRESHOLD=2.0&cancer_study_list=pcawg_icgc_2020&case_set_id=pcawg_icgc_2020_sequenced&data_priority=0&gene_list=TP53%2520KRAS&geneset_list=%20&genetic_profile_ids_PROFILE_COPY_NUMBER_ALTERATION=pcawg_icgc_2020_cna&genetic_profile_ids_PROFILE_MUTATION_EXTENDED=pcawg_icgc_2020_mutations&profileFilter=mutations&tab_index=tab_visualize

I've routed you to the **Survival** tab for the "Pan-cancer analysis of whole genomes" study (PCAWG-ICGC 2020) with TP53 and KRAS queried.

**What you'll see:**
- Kaplan-Meier survival curves comparing different genetic groups
- You can use the survival plot controls to compare:
  - Patients with mutations in **both TP53 and KRAS** (altered in both genes)
  - Patients with mutations in **only KRAS** (altered in KRAS, unaltered in TP53)
  - Other combinations as needed

- Statistical significance (log-rank p-value) will be displayed on the plot
- Median survival times for each group will be shown in the legend

Use the grouping options on the page to customize which patient groups you want to compare for your specific survival analysis.

---

## Model Information
- **model**: us.anthropic.claude-sonnet-4-5-20250929-v1:0
- **temperature**: 0.0
- **max_output_tokens**: 1024
- **thinking_enabled**: False
- **thinking_budget_tokens**: 1024
- **response_time_seconds**: 8.820951686007902
- **agent_type**: cbio-nav-null

### Usage
- **input_tokens**: 574
- **output_tokens**: 392
- **total_tokens**: 966
- **cache_creation_input_tokens**: 0
- **cache_read_input_tokens**: 0

---

*Generated on 2026-02-05 01:41:47*